2022
DOI: 10.1016/j.jchromb.2022.123494
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomycin in human skin tissue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…Since impurities have no therapeutic effect and may pose safety risks, impurity profiling is essential for drug quality control [22]. Given that PRM and its impurities have similar structures without UV-absorbing chromophores, decent detection techniques should be applied, and few LC-based methods for detecting PRM in human biological matrices have been reported [23][24][25][26]. Hertzler et al [27] developed and validated a volatile reversed-phase HPLC-CAD method that identified nine PRM impurities.…”
Section: Introductionmentioning
confidence: 99%
“…Since impurities have no therapeutic effect and may pose safety risks, impurity profiling is essential for drug quality control [22]. Given that PRM and its impurities have similar structures without UV-absorbing chromophores, decent detection techniques should be applied, and few LC-based methods for detecting PRM in human biological matrices have been reported [23][24][25][26]. Hertzler et al [27] developed and validated a volatile reversed-phase HPLC-CAD method that identified nine PRM impurities.…”
Section: Introductionmentioning
confidence: 99%